Global Radiocontrast Agent Market Research Report 2019 by Manufacturers, Regions, Types and Applications

Table of Contents

1 Report Overview

• 1.1 Definition
• 1.2 Manufacturers and Regions Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
• 1.3 Type Overview
• 1.4 Application Overview
• 1.5 Industrial Chain
  • 1.5.1 Radiocontrast Agent Overall Industrial Chain
  • 1.5.2 Upstream
  • 1.5.3 Downstream
  • 1.5.4 Economic/Political Environment

2 Global Radiocontrast Agent Market Assesment by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Radiocontrast Agent Market Performance
• 2.3 USA Radiocontrast Agent Market Performance
• 2.4 Europe Radiocontrast Agent Market Performance
• 2.5 Japan Radiocontrast Agent Market Performance
• 2.6 Korea Radiocontrast Agent Market Performance
• 2.7 India Radiocontrast Agent Market Performance
• 2.8 Southeast Asia Radiocontrast Agent Market Performance
• 2.9 South America Radiocontrast Agent Market Performance

3 Global Radiocontrast Agent Market Assesment by Application

• 3.1 Overall Market Performance (Volume)
• 3.2 China Radiocontrast Agent Market Performance (Volume)
• 3.3 USA Radiocontrast Agent Market Performance (Volume)
• 3.4 Europe Radiocontrast Agent Market Performance (Volume)
• 3.5 Japan Radiocontrast Agent Market Performance (Volume)
• 3.6 Korea Radiocontrast Agent Market Performance (Volume)
• 3.7 India Radiocontrast Agent Market Performance (Volume)
• 3.8 Southeast Asia Radiocontrast Agent Market Performance (Volume)
• 3.9 South America Radiocontrast Agent Market Performance (Volume)

4 Competitive Analysis

• 4.1 GE Healthcare (US)
  • 4.1.1 GE Healthcare (US) Profiles
  • 4.1.2 GE Healthcare (US) Product Information
  • 4.1.3 GE Healthcare (US) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.1.4 GE Healthcare (US) Radiocontrast Agent Business Performance
  • 4.1.5 SWOT Analysis
• 4.2 Bracco Imaging (Italy)
  • 4.2.1 Bracco Imaging (Italy) Profiles
  • 4.2.2 Bracco Imaging (Italy) Product Information
  • 4.2.3 Bracco Imaging (Italy) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.2.4 Bracco Imaging (Italy) Radiocontrast Agent Business Performance
  • 4.2.5 SWOT Analysis
• 4.3 Bayer HealthCare (Germany)
  • 4.3.1 Bayer HealthCare (Germany) Profiles
  • 4.3.2 Bayer HealthCare (Germany) Product Information
  • 4.3.3 Bayer HealthCare (Germany) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.3.4 Bayer HealthCare (Germany) Radiocontrast Agent Business Performance
  • 4.3.5 SWOT Analysis
• 4.4 Guerbet (France)
  • 4.4.1 Guerbet (France) Profiles
  • 4.4.2 Guerbet (France) Product Information
  • 4.4.3 Guerbet (France) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.4.4 Guerbet (France) Radiocontrast Agent Business Performance
  • 4.4.5 SWOT Analysis
• 4.5 Lantheus (US)
  • 4.5.1 Lantheus (US) Profiles
  • 4.5.2 Lantheus (US) Product Information
  • 4.5.3 Lantheus (US) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.5.4 Lantheus (US) Radiocontrast Agent Business Performance
  • 4.5.5 SWOT Analysis
• 4.6 Daiichi Sankyo (Japan)
  • 4.6.1 Daiichi Sankyo (Japan) Profiles
  • 4.6.2 Daiichi Sankyo (Japan) Product Information
  • 4.6.3 Daiichi Sankyo (Japan) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.6.4 Daiichi Sankyo (Japan) Radiocontrast Agent Business Performance
  • 4.6.5 SWOT Analysis
• 4.7 Unijules Life Sciences (India)
  • 4.7.1 Unijules Life Sciences (India) Profiles
  • 4.7.2 Unijules Life Sciences (India) Product Information
  • 4.7.3 Unijules Life Sciences (India) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.7.4 Unijules Life Sciences (India) Radiocontrast Agent Business Performance
  • 4.7.5 SWOT Analysis
• 4.8 J.B. Chemicals and Pharmaceuticals (India)
  • 4.8.1 J.B. Chemicals and Pharmaceuticals (India) Profiles
  • 4.8.2 J.B. Chemicals and Pharmaceuticals (India) Product Information
  • 4.8.3 J.B. Chemicals and Pharmaceuticals (India) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.8.4 J.B. Chemicals and Pharmaceuticals (India) Radiocontrast Agent Business Performance
  • 4.8.5 SWOT Analysis
• 4.9 Spago Nanomedicine (Sweden)
  • 4.9.1 Spago Nanomedicine (Sweden) Profiles
  • 4.9.2 Spago Nanomedicine (Sweden) Product Information
  • 4.9.3 Spago Nanomedicine (Sweden) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.9.4 Spago Nanomedicine (Sweden) Radiocontrast Agent Business Performance
  • 4.9.5 SWOT Analysis
• 4.10 Taejoon Pharm (South Korea)
  • 4.10.1 Taejoon Pharm (South Korea) Profiles
  • 4.10.2 Taejoon Pharm (South Korea) Product Information
  • 4.10.3 Taejoon Pharm (South Korea) Radiocontrast Agent Production, Revenue, Price and Gross Margin
  • 4.10.4 Taejoon Pharm (South Korea) Radiocontrast Agent Business Performance
  • 4.10.5 SWOT Analysis
• 4.11 Jodas (India)
• 4.12 Magnus Health (India)

5 Competitive Landscape

• 5.1 Global Radiocontrast Agent Production (K Units) and Market Share by Manufacturers (2014-2019)
• 5.2 Global Radiocontrast Agent Revenue (M USD) and Market Share by Manufacturers (2014-2019)
• 5.3 Global Radiocontrast Agent Price (USD/Unit) of Manufacturers (2014-2019)
• 5.4 Global Radiocontrast Agent Gross Margin of Manufacturers (2014-2019)
• 5.5 Market Concentration

6 Global Radiocontrast Agent Market Assessment by Regions

• 6.1 Global Radiocontrast Agent Production (K Units) and Market Share by Regions (2014-2019)
• 6.2 Global Radiocontrast Agent Revenue (M USD) and Market Share by Regions (2014-2019)
• 6.3 Global Radiocontrast Agent Price (USD/Unit) by Regions (2014-2019)
• 6.4 Global Radiocontrast Agent Gross Margin by Regions (2014-2019)

7 Radiocontrast Agent Regional Analysis

• 7.1 China Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.2 USA Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.3 Europe Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.4 Japan Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.5 Korea Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.6 India Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.7 Southeast Asia Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)
• 7.8 South America Radiocontrast Agent Production, Revenue and Growth Rate (2014-2019)

8 Global Radiocontrast Agent Consumption Assessment

• 8.1 Global Radiocontrast Agent Consumption and Market Share by Regions (2014-2019)
• 8.2 Global Radiocontrast Agent Consumption Value and Market Share by Regions (2014-2019)
• 8.3 Global Radiocontrast Agent Average Price (USD/Unit) by Regions (2014-2019)

9 Global Radiocontrast Agent Sales Assessment by Regions

• 9.1 Global Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.2 China Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.3 USA Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.4 Europe Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.5 Japan Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.6 Korea Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.7 India Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.8 Southeast Asia Radiocontrast Agent Sales and Sales Value (2014-2019)
• 9.9 South America Radiocontrast Agent Sales and Sales Value (2014-2019)

10 Technology and Cost

• 10.1 Technology
• 10.2 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Market Forecast 2020-2025

• 12.1 Production and Revenue Forecast 2020-2025
  • 12.1.1 Global Radiocontrast Agent Production and Revenue by Regions 2020-2025
  • 12.1.2 China Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.3 USA Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.4 Europe Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.5 Japan Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.6 Korea Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.7 India Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.8 Southeast Asia Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
  • 12.1.9 South America Radiocontrast Agent Production, Revenue and Growth Rate 2020-2025
• 12.2 Sales and Sales Value Forecast 2020-2025
  • 12.2.1 Global Radiocontrast Agent Consumption and Consumption Calue by Regions 2020-2025
  • 12.2.2 Global Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.3 China Radiocontrast Agent Sales, Sales Value and Growth Rate 2020-2025
  • 12.2.4 USA Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.5 Europe Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.6 Japan Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.7 Korea Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.8 India Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.9 Southeast Asia Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
  • 12.2.10 South America Radiocontrast Agent Sales and Sales Value Forecast 2020-2025
• 12.3 Global Radiocontrast Agent Production and Revenue Forecast by Type 2020-2025
  • 12.3.1 Overall Market Performance
  • 12.3.2 By Type
  • 12.3.3 Barium-based Radiocontrast Agent
  • 12.3.4 Iodinated Radiocontrast Agent
  • 12.3.5 Gadolinium-based Radiocontrast Agent
  • 12.3.6 Microbubble Radiocontrast Agent
• 12.4 Global Radiocontrast Agent Sales Forecast by Application 2020-2025
  • 12.4.1 Overall Market Performance
  • 12.4.2 Radiology
  • 12.4.3 Interventional Radiology
  • 12.4.4 Interventional Cardiology
• 12.5 Global Radiocontrast Agent Price and Gross Margin Forecast
  • 13.5.1 Global Radiocontrast Agent Averages Price Development Trend Forecast 2020-2025
  • 13.5.2 Global Radiocontrast Agent Gross Margin Development Trend Forecast 2020-2025

13 Conclusion